Skip to Main Content

Paper Details

Testican-2 Is Associated with Reduced Risk of Incident ESKD.
J Am Soc Nephrol
5
2023
AASK, Atherosclerosis, CRIC, Chronic Renal Insufficiency, ESKD, Hypertension, Kidney Disease, Testican-2, comorbidities, end stage kidney disease, participants, podocyte, proteinuria, testican, testican-, testican-2
Author NameAffiliation
Christie M BallantyneBaylor College of Medicine
Christie M BallantyneBaylor College of Medicine
Michael G Shlipak
Michael G ShlipakUniversity of California san francisco
Sushrut S WaikarBoston University School of Medicine and Boston Medical Center
Ramachandran S VasanBoston University School of Medicine
Ramachandran S VasanBoston University School of Public Health
Josef CoreshJohns Hopkins Bloomberg School of Public Health
Morgan E GramsJohns Hopkins Bloomberg School of Public Health
Morgan E GramsJohns Hopkins University
  • 1 - 10

Datasets

Release 1.2